Skip to main content

Advertisement

Table 2 Baseline characteristics of the study population to date

From: Frailty and physical function in chronic kidney disease: the CanFIT study

Variable Full Cohort (N = 217) SPPB ≥ 10 (N = 95) SPPB < 10 (N = 122)
  Age (years) 70.3 (60–79.1) 62.9 (52.9–72.3) 74.6 (63.4–82.5)
  Gender (Female) 84 (40.0 %) 27 (29.4 %) 57 (48.3 %)
  Weight (kg) 83 (71.7–96.6) 81.2 (72–95.9) 86.1 (71.7–96.6)
  Systolic Blood Pressure (mmHg) 137 (124–151) 135 (123–149) 140 (126–151)
  Diastolic Blood Pressure (mmHg) 74 (66–82) 78 (68–85) 71 (65–78)
  Pulse Pressure (mmHg) 64 (52–76) 59 (48–70) 69.5 (57–79)
Laboratory Values
  eGFR (mL/min/1.73 m2) 19 (14–27) 18 (13–26) 20 (16–27)
  Creatinine (umol/L) 250.5 (189–334) 273.5 (202–404) 229 (186–309)
  Log Urine ACR 3.3 (1–5.1) 3.3 (1.1–5) 3.3 (0.9–5.2)
  Hemoglobin (g/L) 114 (107–124.5) 118 (110–126) 113 (105–122)
  Hemoglobin A1c (%) 6.3 (5.7–7.9) 5.9 (5.5–7.5) 6.8 (5.8–8.1)
  Blood Glucose (mmol/L) 6.6 (5.4–9.6) 6.2 (5.3–8.5) 7.3 (5.5–9.9)
Comorbidities
  Visual or Hearing Impairment 101 (46.5 %) 32 (33.7 %) 69 (56.6 %)
  Hypertension 181 (85.0 %) 76 (80.0 %) 105 (89.0 %)
  Dyslipidemia 133 (63.0 %) 55 (57.9 %) 78 (67.2 %)
  Diabetes (Type I or II) 128 (60.4 %) 40 (42.1 %) 88 (75.2 %)
  Previous MI 29 (13.7 %) 8 (8.4 %) 24 (20.5 %)
  Congestive Heart Failure 31 (14.6 %) 5 (5.3 %) 24 (20.5 %)
  Neurologic Disease 51 (24.1 %) 3 (3.2 %) 9 (7.7 %)
  1. Note: Continuous variables are expressed as Median (Interquartile Range) and compared using Mann–Whitney Test; Categorical variables are expressed as N(%) and compared using Chi-Square or Fisher Exact Test
  2. Neurologic Disease contains stroke, transient ischemic attack and Parkinson’s disease. ACR Albumin Creatinine Ratio, MI Myocardial Infarction